Fetal Medicine Unit, 3rd Department of Obstetrics and Gynaecology, University of Athens Medical School, 'Attikon' University Hospital, Athens, Greece.
Fetal Medicine Unit, Leto Maternity Hospital, Athens, Greece.
Ultrasound Obstet Gynecol. 2019 Mar;53(3):396-401. doi: 10.1002/uog.19050. Epub 2019 Feb 1.
To assess the feasibility and results of introducing a policy of universal screening for preterm delivery (PTD) by mid-trimester cervical-length (CL) measurement.
In this retrospective cross-sectional study of singleton pregnancies, transvaginal sonography for CL measurement was performed at 20-24 weeks of gestation. Vaginal progesterone therapy was offered to women with CL ≤ 15 mm. The incidence of spontaneous PTD (sPTD) according to CL and the distribution of CL measurements were assessed. Rate of PTD before implementation of screening was compared with that after.
A total of 10 506 singleton pregnancies were assessed. The decline rate was 1.32%. sPTD < 32 weeks, < 34 weeks and < 37 weeks occurred in 0.51%, 0.82% and 3.90% of pregnancies, respectively. CL measurement was best described by a mixture model distribution comprising a 'short' and a 'long' component. The percentage of the two components varied between subgroups of PTD, with the short component being greater the earlier the birth. CL, history of miscarriage, smoking status and prior PTD were independent predictors in the construction of a model predictive of PTD < 34 weeks (area under the curve = 0.74, P < 0.001). The rate of sPTD < 34 weeks in women with CL ≤ 15 mm receiving progesterone treatment was 20.4%. In the progesterone-treated group, a plateau was observed in the increase in risk for PTD for CL 9-13 mm, whereas below 9 mm the risk increased exponentially. Following the introduction of mid-trimester CL measurement, there was a trend for reduction in the rate of any PTD < 34 weeks of about 20% in comparison with the prescreening period (odds ratio = 0.81; 95% CI, 0.59-1.13).
Universal screening for PTD by transvaginal sonographic measurement of CL at 20-24 weeks is feasible and well accepted by pregnant women. This policy identifies a very high-risk group that may benefit from intervention. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
评估通过中孕期宫颈长度(CL)测量对早产(PTD)进行普遍筛查的可行性和结果。
在这项对单胎妊娠的回顾性横断面研究中,在 20-24 孕周进行经阴道超声 CL 测量。对 CL≤15mm 的妇女给予阴道孕酮治疗。评估根据 CL 的自发性早产(sPTD)发生率和 CL 测量值的分布。比较筛查实施前后 PTD 的发生率。
共评估了 10506 例单胎妊娠。下降率为 1.32%。sPTD<32 周、<34 周和<37 周分别发生在 0.51%、0.82%和 3.90%的妊娠中。CL 测量值最好用由“短”和“长”两个分量组成的混合模型分布来描述。两个分量的百分比在 PTD 的亚组之间有所不同,分娩越早,短分量越大。CL、流产史、吸烟状况和既往 PTD 是预测 PTD<34 周的模型的独立预测因子(曲线下面积为 0.74,P<0.001)。CL≤15mm 且接受孕酮治疗的妇女 sPTD<34 周的发生率为 20.4%。在孕酮治疗组中,CL9-13mm 时 PTD 风险的增加呈平台趋势,而低于 9mm 时风险呈指数增加。中孕期 CL 测量引入后,与筛查前相比,任何 PTD<34 周的发生率呈约 20%的下降趋势(比值比为 0.81;95%CI,0.59-1.13)。
在 20-24 孕周经阴道超声 CL 测量对 PTD 进行普遍筛查是可行的,并且深受孕妇的欢迎。该策略确定了一个非常高危的群体,可能受益于干预。版权所有©2018 ISUOG。由 John Wiley & Sons Ltd 出版。